Weekly Product Shortages
- Details
- Published: Friday, 17 October 2025 06:00
- Written by 340B Editor
Novo Nordisk recently announced changes to the eligibility criteria for its Patient Assistance Program for 2026.
Effective October 1, 2025, Bausch Health has ended its participation in the 340B Drug Pricing Program. As a result, Bausch products are no longer considered covered outpatient drugs and are not eligible for 340B pricing.
The 340B Drug Pricing Program is managed by the Health Resources and Services Administration (HRSA) Office of Pharmacy Affairs (OPA). For more information visit: www.hrsa.gov/opa This material is provided for general informational purposes of 340B Drug Prices only and is not an endorsement of any prescription product referenced herein. For information as to the clinical use or efficacy of a referenced product, please contact the manufacturer. 340B Price Guide makes no representations and provides no warranties as to the effectiveness or suitability for use of any prescription product referenced herein. Any referenced cost is provided as an estimate only and the actual cost is subject to change at any time and without notice. 340B Price Guide does not guarantee that the cost represented herein will be the actual and pharmacy shall at all times collect amounts due as indicated at the time of adjudication and shall be reimbursed per the terms of its agreement.'